These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15161524)

  • 21. Preparation and analysis of cSNP chip on hepatocellular carcinoma-related genes.
    Wang J; Ni H; Chen L; Liu YX; Chen CB; Song WQ
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):398-402. PubMed ID: 16109524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrolamellar hepatocellular carcinoma.
    Liu S; Chan KW; Wang B; Qiao L
    Am J Gastroenterol; 2009 Oct; 104(10):2617-24; quiz 2625. PubMed ID: 19638962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic imaging and therapy of hepatocellular carcinoma].
    Allgaier HP; Deibert P; Blum HE
    Dtsch Med Wochenschr; 1997 Dec; 122(50):1573-5. PubMed ID: 9445781
    [No Abstract]   [Full Text] [Related]  

  • 24. Fighting the bushfire in HCC trials.
    Schirmacher P; Bedossa P; Roskams T; Tiniakos DG; Brunt EM; Zucman-Rossi J; Manns MP; Galle PR
    J Hepatol; 2011 Aug; 55(2):276-7. PubMed ID: 21439335
    [No Abstract]   [Full Text] [Related]  

  • 25. Current approaches to the diagnosis and management of hepatocellular carcinoma.
    Perry JF; Poustchi H; George J; Farrell GC; McCaughan GW; Strasser SI
    Clin Exp Med; 2005 May; 5(1):1-13. PubMed ID: 15928877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of hepatocellular carcinoma. Questions for Professor Michel Beaugrand].
    Beaugrand M
    Gastroenterol Clin Biol; 2002 Jan; 26(1):84-6. PubMed ID: 11938047
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatocellular carcinoma - diagnosis and treatment].
    Greten TF; Manns MP
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1907-10. PubMed ID: 18785082
    [No Abstract]   [Full Text] [Related]  

  • 28. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
    Zhang T; Sun HC; Xu Y; Zhang KZ; Wang L; Qin LX; Wu WZ; Liu YK; Ye SL; Tang ZY
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8557-63. PubMed ID: 16361537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene-chip analysis of the effect of tripeptide tyroservatide (YSV) on gene-expression in human hepatocarcinoma BEL-7402 tumors transplanted to nude mice.
    Jia J; Lu R; Zhou C; Zhao L; Fu Z; Zhu Z; Wang L; Zheng M; Yang J; Zhang Y; Yao Z
    Mol Carcinog; 2006 Mar; 45(3):197-203. PubMed ID: 16353255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
    Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
    Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of multicentric occurrence of hepatocellular carcinoma].
    He ZP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):187-9. PubMed ID: 15059316
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gene therapy in liver diseases].
    Pár A; Lakatos PL; Abonyi M; Szalay F; Nagy Z; Mózsik G
    Orv Hetil; 2002 Jan; 143(3):125-9. PubMed ID: 11883109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of hepatocellular carcinoma.
    El-Serag HB; Marrero JA; Rudolph L; Reddy KR
    Gastroenterology; 2008 May; 134(6):1752-63. PubMed ID: 18471552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of small hepatocellular carcinoma.
    Sherman M
    Hepatology; 2005 Jul; 42(1):14-6. PubMed ID: 15962322
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of hepatocellular carcinoma.
    De Giorgio M; Fagiuoli S
    Dig Dis; 2007; 25(3):279-81. PubMed ID: 17827957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
    Panzitt K; Tschernatsch MM; Guelly C; Moustafa T; Stradner M; Strohmaier HM; Buck CR; Denk H; Schroeder R; Trauner M; Zatloukal K
    Gastroenterology; 2007 Jan; 132(1):330-42. PubMed ID: 17241883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.
    Schepelmann S; Hallenbeck P; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Hay C; Hawkins LK; Marais R; Springer CJ
    Cancer Res; 2005 Jun; 65(12):5003-8. PubMed ID: 15958540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Towards early screening and treatment of hepatocellular carcinoma cirrhosis?].
    Roudot-Thoraval F; Dhumeaux D
    Gastroenterol Clin Biol; 2002; 26(6-7):559-60. PubMed ID: 12193853
    [No Abstract]   [Full Text] [Related]  

  • 40. The molecular point of view of hepatocellular carcinoma.
    Benzoni E
    J Surg Oncol; 2008 Jun; 97(7):565-6. PubMed ID: 18491361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.